EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Seizures Associated with Autoimmune Disorders — Current Treatment Approaches

Lisa Gillinder iD, Jeffrey W Britton

Seminars in Neurology · 01.04.2025 · 45 (02) · 275-286

DOI: 10.1055/a-2525-3511 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Neurology, erschienen am 01.04.2025. Verfasst von Lisa Gillinder und 1 weiteren Autor:innen. Beteiligte Einrichtung: Princess Alexandra Hospital, Woolloongabba Qld, Australia. Hauptthemen laut MEDLINE: Seizures, Autoimmune Diseases, Epilepsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 88 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune-associated seizures and epilepsy are increasingly recognized in clinical practice and can arise in the setting of acute encephalitis but in some cases may present with chronic focal epilepsy. These conditions are usually resistant to antiseizure therapy but may respond definitively to timely immunotherapy. Early diagnosis and treatment are critical to minimize neural injury and optimize outcomes. Treatment is guided by consensus opinion because definitive trials are currently lacking. The initial management approach usually involves first-line agents such as corticosteroids, intravenous immunoglobulin (IVIg), or plasma exchange, with second-line agents like rituximab or cyclophosphamide. Maintenance therapy is considered to prevent relapses, which occur in up to 35% of patients. Relapse management requires careful differentiation from postencephalitic epilepsy, which in the absence of active inflammation does not respond to immunotherapy. This review discusses treatment strategies for autoimmune-associated seizure disorders, including acute symptomatic seizures and epilepsy. We discuss expected outcomes on the basis of the underlying pathogenesis including cases mediated by autoantibodies targeting specific neuronal surface/synaptic antigens, and intracellular epitopes, and for cases lacking defined biomarkers. Specific approaches are outlined for disorders such as anti-LGI1, anti-NMDAR, anti-GABA-BR, and anti-GAD65 encephalitides, emphasizing tailored immunotherapy based on pathophysiology and clinical context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SeizuresAutoimmune DiseasesEpilepsyHumansImmunotherapy

Autor:innen und Institutionen

  • Princess Alexandra Hospital, Woolloongabba Qld, Australia.
  • School of Medicine, the University of Queensland, Brisbane, Australia.
  • Epilepsy Division, Department of Neurology, Mayo Clinic, Rochester, Minnesota.

ORCID-Profile: Lisa Gillinder

Zitieren

APA

Gillinder, L., & Britton, J. W. (2025). Seizures Associated with Autoimmune Disorders — Current Treatment Approaches. Seminars in Neurology, 45(02), 275-286. https://doi.org/10.1055/a-2525-3511

Vancouver

Gillinder L, Britton JW. Seizures Associated with Autoimmune Disorders — Current Treatment Approaches. Seminars in Neurology. 2025;45(02):275-286. doi:10.1055/a-2525-3511

BibTeX
@article{Gillinder2025,
  author = {Gillinder, Lisa and Britton, Jeffrey W},
  title = {Seizures Associated with Autoimmune Disorders — Current Treatment Approaches},
  journal = {Seminars in Neurology},
  year = {2025},
  volume = {45},
  number = {02},
  pages = {275--286},
  doi = {10.1055/a-2525-3511}
}
Kostenlos starten →